Transcutaneous immunization: A human vaccine delivery strategy using a patch

Nature Medicine

Volumn 6, Issue 12, 2000, Pages 1403-1406

  Glenn, Gregory M ^a,b   Taylor, David N ^a   Li, Xiuru ^b   Frankel, Sarah ^c   Montemarano, Andrew ^d   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b IOMAI Corporation   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SAFETY; ENTERITIS; HISTOPATHOLOGY; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; SKIN BIOPSY;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; BACTERIAL TOXINS; BACTERIAL VACCINES; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; VACCINATION;

EID: 0034528538     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/82225     Document Type: Article

References (25)

1. Skin immunization made possible by cholera toxin
2. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins
3. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
4. Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant
5. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
6. Reducing the risk of unsafe injections in immunization programmes: The role of injection equipment
7. Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy
8. Dermatologic formulations
9. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization
10. Antitoxic immunity in experimental cholera: Protection and serum and local antibody responses in rabbits after enteric and parenteral immunization
11. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial
12. Phenotypic and functional characteristics of in vivo activated Langerhans cells
13. Microanatomical distribution of dendritic cells in normal tonsils
14. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
15. Advances in vaccine delivery: Transcutaneous immunisation
16. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis
17. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice
18. Diversity of antibody-mediated immunity at the mucosal barrier
19. Water, the most natural penetration enhancer
20. Effect on systemic antibody concentrations of topical application of cholera toxin to skin of sheep
21. Cadherins and Langerhans cells immunobiology
22. Immunization through dermal delivery of protein-encoding DNA: A role for migratory dendritic cells
23. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants
24. Serologic differentation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli
25. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit